Designing serological assays with high diagnostic potential

In the hopes of creating a more accurate and highly informative diagnostic test, CITF-funded investigator Dr. Andrei Drabovich (University of Alberta) and colleagues have designed and evaluated the performance of novel serological assays to measure the presence of SARS-CoV-2 antibodies in blood and saliva. Their study is published in Analytical Chemistry.